Bringing you the latest cutting-edge research and commentary in bioscience.

Cell & Gene Therapy Insights

Cell & Gene Therapy Insights

Interview
Spotlight Article

From NCATS to NASA: the extraordinary potential of tissue chips

Meeting Preclinical Data Requirements For Cell & Gene Therapies

Lucie Low

Lucie Low is the scientific program manager of the trans-NIH Tissue Chip for Drug Screening program at the National Center for Advancing Translational Sciences (NCATS). She also serves as the NIH-NASA liaison point of contact, facilitating collaborations between NIH and NASA on areas of overlapping agency interest. Prior to joining NCATS in 2016, Low was an intramural research fellow at the National Center for Complementary and Integrative Health (NCCIH), researching the complex interactions between pain, emotion and cognition. She obtained her undergraduate degree from Magdalen College, Oxford University, and her Masters and PhD degrees in Neuroscience from University College London in the UK. She undertook postdoctoral training at McGill University in Montreal, Canada, before joining the US National Institutes of Health in 2012. She has authored over 20 peer-reviewed manuscripts on the neuroscience of pain and tissue chips.

DOI: 10.18609/cgti.2019.093
Citation: Cell & Gene Therapy Insights 2019; 5(7), 873-883.
Open access
This content is restricted to registered users. Click here to Register or Login here.
Twitter IconVisit Our Blog